6th NovAliX Conference

Biophysics in Drug Discovery 2019 | European Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Cannes, France    March 20-22, 2019

Committee


NovAliX Conferences Chairman & Scientific Organiser

Chairman

 Jean-Paul RENAUD
Dr Jean-Paul RENAUD

NovAliX & RiboStruct, Illkirch, France

Scientific Committee

Members

 Chun-wa CHUNG
Dr Chun-wa CHUNG

GlaxoSmithKline, Stevenage, United Kingdom

 Helena DANIELSON
Prof. Helena DANIELSON

Uppsala University, Uppsala, Sweden

 Ursula EGNER
Dr Ursula EGNER

Bayer, Berlin, Germany

 Matthias FRECH
Dr Matthias FRECH

Merck, Darmstadt, Germany

 Stefan GESCHWINDNER
Dr Stefan GESCHWINDNER

AstraZeneca, Mölndal, Sweden

 Michael HENNIG
Dr Michael HENNIG

leadXpro, Villigen, Switzerland

 Sylwia HUBER
Dr Sylwia HUBER

F. Hoffmann-La Roche, Basel, Switzerland

 Sandra JACOB
Dr Sandra JACOB

Novartis, Basel, Switzerland

 Herbert NAR
Dr Herbert NAR

Boehringer Ingelheim, Biberach, Germany

 Jean-Paul RENAUD
Dr Jean-Paul RENAUD

NovAliX & RiboStruct, Illkirch, France